NCT06576050View on ClinicalTrials.gov

WeighT LOSS Surgery and Comprehensive Cardiometabolic Responses to to EXercise

Active, not recruitingOBSERVATIONAL

Enrollment

21

Participants

Timeline

Start Date

January 25, 2022

Primary Completion Date

August 2, 2024

Study Completion Date

November 1, 2024

Conditions

Heart FailureObesityWeight LossHeart Failure With Preserved Ejection Fraction

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Amgen

INDUSTRY

lead

Massachusetts General Hospital

OTHER